November 19, 2020 Regulatory Promore Pharma meddelar positiva resultat från fas IIb-studie av ropocamptide vid behandling av venösa bensår
November 19, 2020 Regulatory Promore Pharma announces positive results from Phase IIb study of ropocamptide in the treatment of venous leg ulcers
May 26, 2020 Regulatory Report from the Annual General Meeting of Promore Pharma AB held on 26 May 2020
March 24, 2020 Regulatory Promore Pharma nådde målsättningen i antalet behandlade patienter i den kliniska fas IIb-studien HEAL LL-37
March 24, 2020 Regulatory Promore Pharma reached the targeted number of patients completing treatment in the HEAL LL-37 Phase IIb clinical trial